Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.
暂无分享,去创建一个
P D Griffiths | M. Paley | P. Griffiths | P. Griffiths | R. Grünewald | N. Hoggard | M N Paley | J. Graham | N Hoggard | R A Grünewald | J M Graham
[1] R. A. Knight,et al. ASSESSMENT OF RELATIVE BRAIN IRON CONCENTRATIONS USING T-2-WEIGHTED AND T-2(ASTERISK)-WEIGHTED MRI AT 3-TESLA , 1994 .
[2] M. Horstink,et al. Cognitive and motor shifting aptitude disorder in Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.
[3] A. Crossman. Neural mechanisms in disorders of movement. , 1989, Comparative biochemistry and physiology. A, Comparative physiology.
[4] Bonnet Am. [The Unified Parkinson's Disease Rating Scale]. , 2000 .
[5] H. M. Swartz,et al. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain , 1996, Neuroscience.
[6] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[7] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[8] D Gadian,et al. Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[9] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[10] H. Nelson. A Modified Card Sorting Test Sensitive to Frontal Lobe Defects , 1976, Cortex.
[11] R M Henkelman,et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. , 1993, AJNR. American journal of neuroradiology.
[12] Y. Agid,et al. Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys , 1995, Brain Research.
[13] R. Brooks,et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. , 1999, Radiology.
[14] C. Marsden,et al. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease , 1994, Annals of neurology.
[15] P D Griffiths,et al. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. , 1993, Dementia.
[16] Peter Riederer,et al. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.
[17] T. Shima,et al. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study. , 1997, Free radical biology & medicine.
[18] C D Marsden,et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.
[19] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[20] S. Houle,et al. In vivo evaluation of [11C]- and [18F]-labelled cocaine analogues as potential dopamine transporter ligands for positron emission tomography. , 1996, Nuclear medicine and biology.
[21] P. Boesiger,et al. T2 relaxation time in patients with Parkinson's disease , 1993, Neurology.
[22] K. Jellinger,et al. Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.
[23] C. W. Olanow,et al. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.
[24] F. Ye,et al. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance , 1996, Movement disorders : official journal of the Movement Disorder Society.
[25] D. C. Howell. Statistical Methods for Psychology , 1987 .
[26] A. Lees,et al. Cognitive deficits in the early stages of Parkinson's disease. , 1983, Brain : a journal of neurology.
[27] R. Ordidge,et al. Assessment of relative brain iron concentrations using T2‐weighted and T2*‐weighted MRI at 3 Tesla , 1994, Magnetic resonance in medicine.
[28] J. Degroot,et al. Magnetic resonance imaging of the midbrain in Parkinson's disease , 1986, Annals of neurology.
[29] P. Ryvlin,et al. Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease. , 1995, Archives of neurology.
[30] R. Ordidge,et al. Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease , 1995, Neurology.
[31] P Z Marmarelis,et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. , 1999, Magnetic resonance imaging.
[32] P D Griffiths,et al. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.
[33] J. Connor,et al. Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions , 1995, Journal of neurochemistry.
[34] G A Johnson,et al. MRI of brain iron. , 1986, AJR. American journal of roentgenology.
[35] W H Oldendorf,et al. Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores , 1993, Magnetic resonance in medicine.
[36] R I Grossman,et al. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes , 1989, Neurology.
[37] Moussa B. H. Youdim,et al. Brain iron : neurochemical and behavioural aspects , 1988 .
[38] C. Marsden,et al. INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAIN , 1987, The Lancet.
[39] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[40] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[41] S. Weis,et al. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[42] F. Ye,et al. Increased Basal Ganglia Iron in Striatonigral Degeneration: In Vivo Estimation with Magnetic Resonance , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[43] B. Hallgren,et al. THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.
[44] K. Swaiman,et al. Iron uptake by mammalian cortical neurons , 1984, Annals of neurology.
[45] R. Ordidge,et al. The measurement of R2, R2* and R2' in HIV-infected patients using the prime sequence as a measure of brain iron deposition. , 1997, Magnetic resonance imaging.
[46] A. Lees,et al. Parkinson's Disease Society Brain Bank, London: overview and research. , 1993, Journal of neural transmission. Supplementum.
[47] C. Pert,et al. Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[48] H. Nelson,et al. Dementia: The Estimation of Premorbid Intelligence Levels Using the New Adult Reading Test , 1978, Cortex.
[49] R. Switzer,et al. The regional distribution and cellular localization of iron in the rat brain , 1984, Neuroscience.